Optimizing ChatGPT's performance in hypertension care: Correspondence

IF 2.7 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Hinpetch Daungsupawong PhD, Viroj Wiwanitkit MD
{"title":"Optimizing ChatGPT's performance in hypertension care: Correspondence","authors":"Hinpetch Daungsupawong PhD,&nbsp;Viroj Wiwanitkit MD","doi":"10.1111/jch.14850","DOIUrl":null,"url":null,"abstract":"<p>Dear Editor,</p><p>We would like to discuss “Enhancing clinical decision-making: Optimizing ChatGPT's performance in hypertension care.<span><sup>1</sup></span>” Artificial intelligence, particularly conversational models such as OpenAI's ChatGPT, has profoundly impacted several industries, including the healthcare sector. It is a useful tool in medical research and treatment because of its capacity to analyze large volumes of data and mimic human speech. With its ability to provide recommendations and individualized health monitoring, ChatGPT holds great potential to transform patient care. For best usage in healthcare settings, there are still several areas where it falls short, such as the use of dated data and the absence of clinical judgment and individualized treatment suggestions.</p><p>One new highlight is the potential enhancements and optimizations that ChatGPT could bring to hypertension management. By summarizing guidelines, updating information, and providing decision support tools, ChatGPT can improve diagnostic accuracy, tailor treatments, and ultimately enhance patient outcomes. Additionally, as an education tool, ChatGPT can simplify complex medical topics for both patients and healthcare professionals, fostering ongoing learning and improving clinical reasoning. Research and evidence synthesis capabilities of ChatGPT can help healthcare providers make informed clinical decisions through concise overviews of the latest studies and treatments in hypertension management. The fact that ChatGPT may produce incoherent and unhelpful results is a prevalent concern. Temsah et al. stated that because of their unreliability, the present forms of ChatGPT and other Chatbots should not be employed for diagnostic or treatment purposes without human expert oversight.<span><sup>2</sup></span></p><p>Future directions for ChatGPT in hypertension care include increasing its performance by selecting advanced models, customizing user profiles, and integrating clinical guidelines. Staying updated with research findings, creating a feedback loop for continuous improvement, and complementing professional judgment are essential steps for maximizing the utility of ChatGPT in clinical decision-making. Ethical considerations and limitations, such as privacy and security concerns, should also be addressed when using AI tools in healthcare settings. Collaborative efforts among technology developers, healthcare professionals, and patients are crucial for tailoring ChatGPT to meet the diverse needs of all stakeholders and optimizing patient care in the future.</p><p>Another obstacle to integration is the potential for bias in AI algorithms. If the data used to train the LLMs is not representative of all patient populations, it can lead to inaccurate or discriminatory outcomes. To address this issue, efforts must be made to ensure diverse and inclusive datasets are used in training AI algorithms. Regular audits and monitoring of AI systems can also help identify and correct bias in real-time.<span><sup>3</sup></span></p><p>Hinpetch Daungsupawong 50% ideas, writing, analyzing, and approval. Viroj Wiwanitkit 50% ideas, supervision, and approval.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232440/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14850","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Editor,

We would like to discuss “Enhancing clinical decision-making: Optimizing ChatGPT's performance in hypertension care.1” Artificial intelligence, particularly conversational models such as OpenAI's ChatGPT, has profoundly impacted several industries, including the healthcare sector. It is a useful tool in medical research and treatment because of its capacity to analyze large volumes of data and mimic human speech. With its ability to provide recommendations and individualized health monitoring, ChatGPT holds great potential to transform patient care. For best usage in healthcare settings, there are still several areas where it falls short, such as the use of dated data and the absence of clinical judgment and individualized treatment suggestions.

One new highlight is the potential enhancements and optimizations that ChatGPT could bring to hypertension management. By summarizing guidelines, updating information, and providing decision support tools, ChatGPT can improve diagnostic accuracy, tailor treatments, and ultimately enhance patient outcomes. Additionally, as an education tool, ChatGPT can simplify complex medical topics for both patients and healthcare professionals, fostering ongoing learning and improving clinical reasoning. Research and evidence synthesis capabilities of ChatGPT can help healthcare providers make informed clinical decisions through concise overviews of the latest studies and treatments in hypertension management. The fact that ChatGPT may produce incoherent and unhelpful results is a prevalent concern. Temsah et al. stated that because of their unreliability, the present forms of ChatGPT and other Chatbots should not be employed for diagnostic or treatment purposes without human expert oversight.2

Future directions for ChatGPT in hypertension care include increasing its performance by selecting advanced models, customizing user profiles, and integrating clinical guidelines. Staying updated with research findings, creating a feedback loop for continuous improvement, and complementing professional judgment are essential steps for maximizing the utility of ChatGPT in clinical decision-making. Ethical considerations and limitations, such as privacy and security concerns, should also be addressed when using AI tools in healthcare settings. Collaborative efforts among technology developers, healthcare professionals, and patients are crucial for tailoring ChatGPT to meet the diverse needs of all stakeholders and optimizing patient care in the future.

Another obstacle to integration is the potential for bias in AI algorithms. If the data used to train the LLMs is not representative of all patient populations, it can lead to inaccurate or discriminatory outcomes. To address this issue, efforts must be made to ensure diverse and inclusive datasets are used in training AI algorithms. Regular audits and monitoring of AI systems can also help identify and correct bias in real-time.3

Hinpetch Daungsupawong 50% ideas, writing, analyzing, and approval. Viroj Wiwanitkit 50% ideas, supervision, and approval.

The authors declare no conflicts of interest.

优化 ChatGPT 在高血压护理中的表现:通信。
亲爱的编辑,我们想就 "增强临床决策:人工智能,尤其是诸如 OpenAI 的 ChatGPT 这样的对话模型,已经对包括医疗保健领域在内的多个行业产生了深远影响。人工智能能够分析大量数据并模仿人类语言,因此是医学研究和治疗的有用工具。凭借其提供建议和个性化健康监测的能力,ChatGPT 具有改变病人护理的巨大潜力。要想在医疗环境中达到最佳使用效果,它仍有一些不足之处,如使用过时的数据、缺乏临床判断和个性化治疗建议等。通过总结指南、更新信息和提供决策支持工具,ChatGPT 可以提高诊断的准确性,量身定制治疗方案,并最终提高患者的治疗效果。此外,作为一种教育工具,ChatGPT 还能为患者和医疗保健专业人员简化复杂的医学课题,促进持续学习,提高临床推理能力。ChatGPT 的研究和证据综述功能可以通过简明扼要地概述高血压管理的最新研究和治疗方法,帮助医疗服务提供者做出明智的临床决策。ChatGPT 可能会产生不连贯和无益的结果,这是一个普遍关注的问题。Temsah 等人指出,由于 ChatGPT 和其他 Chatbots 不可靠,因此在没有人类专家监督的情况下,不应将目前形式的 ChatGPT 用于诊断或治疗2。不断更新研究成果、建立持续改进的反馈回路以及补充专业判断是最大限度发挥 ChatGPT 在临床决策中的作用的必要步骤。在医疗环境中使用人工智能工具时,还应考虑到伦理因素和局限性,如隐私和安全问题。技术开发人员、医疗保健专业人员和患者之间的合作对于定制 ChatGPT 以满足所有利益相关者的不同需求以及优化未来的患者护理至关重要。如果用于训练 LLM 的数据不能代表所有患者群体,就可能导致不准确或歧视性的结果。为解决这一问题,必须努力确保在训练人工智能算法时使用多样化和包容性的数据集。对人工智能系统进行定期审核和监控也有助于实时识别和纠正偏见。作者声明无利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信